Gastric cancer
Expanding the tumour cell catalogue
16 Sep 2022New gastric cancer insights come to light with the help of powerful single-cell technologies.
Bringing a major culprit in advanced gastric cancer to light
5 Jul 2022Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.
How EBV guts us in new ways
11 Feb 2021The Epstein-Barr virus can cause epigenetic changes that persist even after the infection has been cleared, highlighting why prevention is better than cure when it comes to gastric cancer.
Marking out gastric (cancer) stem cells
10 Jun 2020A*STAR scientists have uncovered a novel surface marker that identifies stem cells and potential cancer stem cells in the distal stomach.
Identifying stomach cancer risk
7 Aug 2018Genetic and epigenetic testing of samples from people with cellular changes to the stomach lining could help predict their risk of developing cancer
Tracking down suspected cancer-inducing mutations using machine learning
7 Aug 2018Machine learning helps locate dozens of mutations statistically linked to gastric cancer in non-coding DNA regions
The stomach’s ‘chief’ source of stem cells
22 Mar 2018Stem cell reserves found in the stomach have
implications for the genesis of gastric cancer
Diagnostic tools in the fast lane
21 Dec 2017Diagnostic tests are the key to the early detection and treatment of
diseases — and Singapore’s Diagnostics Development (DxD) Hub is accelerating the rate at which devices make it from the lab to market.
Genetic dysregulation helps stomach tumors hide
18 Oct 2017Alterations in gene
regulation make gastric cancer cells less visible to the immune system
Powerful switches discovered
25 Jul 2017First roadmap of stomach cancer super-enhancers paves the way for new treatments.
Tracking stem cells in the stomach lining
8 Sep 2016Stem cell behavior revealed by a combination of modeling and microscopy
Gastric cancer subtypes promise tailored treatment
29 Apr 2015The genetic signatures of gastric cancer cell lines reveal disease subtypes with different drug sensitivities